×

Hydrogel-driven layered drug dosage form

  • US 6,899,896 B2
  • Filed: 12/20/2000
  • Issued: 05/31/2005
  • Est. Priority Date: 12/23/1999
  • Status: Expired due to Fees
First Claim
Patent Images

1. A dosage form for the controlled release of sertraline, comprising:

  • (a) a core comprising a sertraline-containing composition and a water-swellable composition wherein said water-swellable composition is in a separate region within said core;

    (b) said sertraline-containing composition comprising sertraline and polyethylene oxide wherein sertraline makes up at least about 20 wt % of said sertraline-containing composition; and

    (c) a coating around said core that is water-permeable, water-insoluble and has at least one delivery port therethrough;

    wherein sertraline is in the form of a pharmaceutically acceptable salt thereof and, following introduction of said dosage form to an environment of use, said dosage form releases sertraline to said environment of use at an average rate of from about 6 to 10 wt % per hour from the second to the twelfth hour and releases less than about 25 wt % for the first two hours and releases at least 70 wt % by the twelfth hour.

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×